ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Ketamine Hydrochloride Injection shortage

To Be Discontinued  1 presentations · 1 manufacturers · first FDA posting Nov 7, 2025 · last update Nov 7, 2025

Manufacturers: Pfizer Inc.

Stated reasons (per FDA): Not stated

More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10)Pfizer Inc.To Be Discontinued
—Discontinuation of the manufacture of the drugPosted Nov 7, 2025
Updated Nov 7, 2025
Discontinued Nov 7, 2025

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)

Free, weekly, unsubscribe anytime. Privacy.